...
首页> 外文期刊>The American Journal of Cardiology >Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)
【24h】

Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)

机译:C反应蛋白在急性心肌梗死患者经皮冠状动脉介入治疗后作为造影剂诱发的肾病的预测指标的有用性和新的危险评分(Athens CIN评分)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Contrast-induced nephropathy (CIN) after percutaneous coronary interventions (PCI) in patients with acute myocardial infarction (AMI) is associated with high morbidity and mortality, whereas there are no reliable predictive tools easy to use. We evaluated the association of pre-procedural high-sensitivity C-reactive protein (hsCRP) with the development of CIN and integrated this variable in a new risk CIN prediction model. Consecutive patients (348 AMI subjects) who underwent PCI were recruited. Creatinine levels were detected on admission, at 24, 48, and 72 hours after PCI. CIN was defined using the Kidney Disease: Improving Global Outcomes criteria. In our study population (348 subjects), CIN developed in 54 patients (15.5%). Patients with CIN were older and had higher hsCRP at admission, whereas their ejection fraction (EF) and glomerular filtration rate (GFR) were lower. In multivariate analysis after incorporating potential confounders, hsCRP at admission was an independent predictor of CIN (OR for logCRP 2.00, p = 0.01). In receiver-operating characteristic curve analysis, a model incorporating hsCRP, age, GFR, and EF showed good accuracy in predicting the development of CIN (c statistic 0.84, 95% confidence interval 0.793 to 0.879). A total risk score derived from the proposed model yielded significant positive and negative predictive values and classified 85.8% of our patients correctly for CIN. In conclusion, measuring hsCRP levels at admission in patients who underwent PCI for AMI may offer additional assistance in predicting the development of CIN. A model incorporating age and admission hsCRP, EF, and GFR emerged as an accurate tool for predicting CIN in this context. (C) 2016 Elsevier Inc. All rights reserved.
机译:急性心肌梗死(AMI)患者经皮冠状动脉介入治疗(PCI)后的造影剂诱发的肾病(CIN)与高发病率和高死亡率相关,但尚无易于使用的可靠预测工具。我们评估了术前高敏C反应蛋白(hsCRP)与CIN发展的关联,并将此变量整合到新的CIN风险预测模型中。招募了接受PCI的连续患者(348例AMI患者)。入院时,PCI后24、48和72小时检测到肌酐水平。使用肾脏疾病:改善总体结果标准定义CIN。在我们的研究人群(348名受试者)中,有54名患者(15.5%)发展为CIN。 CIN患者年龄较大,入院时hsCRP较高,而其射血分数(EF)和肾小球滤过率(GFR)较低。在纳入潜在的混杂因素后的多变量分析中,入院时的hsCRP是CIN的独立预测因子(logCRP 2.00为OR,p = 0.01)。在接收者操作特征曲线分析中,包含hsCRP,年龄,GFR和EF的模型在预测CIN的发展方面显示出良好的准确性(c统计量0.84,95%置信区间0.793至0.879)。从建议的模型得出的总风险评分产生了显着的阳性和阴性预测值,并正确分类了我们患者的CIN的85.8%。总之,在接受PCI的AMI患者中测量入院时的hsCRP水平可能有助于预测CIN的发展。在这种情况下,结合年龄和入院hsCRP,EF和GFR的模型已成为预测CIN的准确工具。 (C)2016 Elsevier Inc.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号